Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-03-23
2009-11-17
Carlson, Karen Cochrane (Department: 1656)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07618787
ABSTRACT:
A method for screening a pro-apoptotic compound comprising a determination step of determining a compound enhancing interaction between p73 and IKK-α as a pro-apoptotic compound.
REFERENCES:
YinLing Hu, et al., “Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase”,Science, vol. 284, Apr. 9, 1999, pp. 316-320.
Catherine H. Regnier, et al., “Identification and Characterization of an IκB Kinase”,Cell, vol. 90, Jul. 25, 2997, pp. 373-383.
Rakesh K. Srivastava, et al., “Deletion of the loop region of Bc1-2 completely blocks paclitaxel-induced apoptosis”,Proc. Natl. Acad. Sci., vol. 96, Mar. 1999, pp. 3775-3780.
JianGen Gong, et al., “The tyrosine kinase c-Ab1 regulates p73 in apoptotic response to cisplatin-induced DNA damage”,Nature, vol. 399, Jun. 24, 2999, pp. 806-809.
Reuven Agami, et al., “Interaction of c-Ab1 and p73α and their collaboration to induce apoptosis”,Nature, vol. 399, Jun. 24, 1999, pp. 809-813.
Zhi-min Yuan, et al., “p73 is regulated by tyrosine kinase c-Ab1 in the apoptotic response to DNA damage”,Nature, vol. 399, Jun. 24, 1999, pp. 814-817.
Yoshiaki Shikama, et al., “Caspase-8 and caspase-10 activate NF-κB through RIP, NIK and IKKα kinases”,Eur. J. Immunol., vol. 33, No. 7, Jul. 2003, pp. 1998-2006.
Y. Wan et al., “The Survival of Antigen-Stimulated T Cells Requires NFkB-Mediated Inhibition of p73 Expression”, Immunity, vol. 18, Mar. 2003, pp. 331-342.
V. Tergaonkar et al., “p53 stabilization is decreased upon NFkB activation: A role for NFkB in acquisition of resistance to chemotherapy”, Cancer Cell, vol. 1, Jun. 2002, pp. 493-503.
G. Webster et al., “Transcriptional Cross Talk between NF-kB and p53”, Molecular and Cellular Biology, May 1999, pp. 3485-3495.
K. Ryan et al., “Role of NF-kB in p53-mediated programmed cell death”, Nature, vol. 404, Apr. 20, 2000, pp. 892-897.
H. Wu et al., “NF-kB Activation of p53: A Potential Mechanism for Suppressing Cell Growth in Response to Stress”,.The Journal of Biological Chemistry, vol. 269, No. 31, Aug. 5, 1994, pp. 20067-20074.
X. Sun et al., “Identification of a Novel p53 Promoter Element Involved in Genotoxic Stress-Inducible p53 Gene Expression”, Molecular and Cellular Biology, vol. 15, No. 8, Aug. 1995, pp. 4489-4496.
A. Hellin et al., “Nuclear factor—κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug”, Oncogene 16, 1998, pp. 1187-1195.
M. Koegl et al., “A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly”, Cell, vol. 96, Mar. 5, 1999, pp. 635-644.
S. Hatakeyama et al., “U Box Proteins as a New Family of Ubiquitin-Protein Ligases”, The Journal of Biological Chemistry, vol. 276, No. 35, Aug. 31, 2001, pp. 33111-33120.
M. Ohira et al., “Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line”, Oncogene 19, (2000), pp. 4302-4307.
J. Mahoney et al., “The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis”, Biochem. J.361, (2002), pp. 587-595.
Y. Bayon et al., “Inhibition of IkB Kinase by a New Class of Retinoide-Related Anticancer Agents That Induce Apoptosis”, Molecular and Cellular Biology, Feb. 2003, pp. 1061-1074.
G. Melino et al., “p73: Friend of Foe in Tumorigenesis”, Nature Reviews Cancer, vol. 2, Aug. 2002, pp. 605-615.
K. Vousden et al., “Live or Let Die: The Cell's Response to p53”, Nature Reviews Cancer, vol. 2, Aug. 2002, pp. 594-604.
A. Birbach et al., “Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus”, The Journal of Biological Chemistry, vol. 277, No. 13, Mar. 29, 2002, pp. 10842-10851.
Y. Yamamoto et al., “Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression”, Nature, vol. 423, Jun. 2003, pp. 655-659.
V. Anest et al., “A nucleosomal function for IkB kinase-α in NF-kB-dependent gene expression”, Nature, vol. 423, Jun. 2003, pp. 659-663.
C. Lee et al., “Promoter specificity and stability control of the p53-related protein p73”, Oncogene 18, (1999), pp. 4171-4181.
L.Ling et al., “NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176”, Proc. Natl. Acad. Sci. USA, vol. 95, Mar. 1998, pp. 3792-3797.
“Inhibitor of nuclear factor kappa-B kinase subunit alpha”, Database UniProt [Online], retrieved from EBI accession No. UNIPROT:015111, Database accession No. 015111, Jan. 1, 1998 (XP002466446).
F. Kazushige et al., “Stabilization of p73 by nuclear I kappa B kinase-alpha mediates cisplatin-induced apoptosis”, Journal of Biological Chemistry, vol. 282, No. 25, ISSN:0021-9258, Jun. 2007, pp. 18365-18378, (XP00246445).
Nakagawara Akira
Ozaki Toshinori
Carlson Karen Cochrane
Chiba-Prefecture
Hisamitsu Pharmaceutical Co. Inc.
Sughrue & Mion, PLLC
LandOfFree
Method of screening compound capable of accelerating or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of screening compound capable of accelerating or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening compound capable of accelerating or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4074925